• Apellis Receives Negative CHMP Opinion for Pegcetacoplan for Geographic Atrophy (GA) in the EU Following Re-Examination | Morningstar

    来源: Buzz FX / 20 9月 2024 06:27:18   America/New_York


    [GlobeNewswire](/news/globe-newswire) Apellis Receives Negative CHMP Opinion for Pegcetacoplan for Geographic Atrophy (GA) in the EU Following Re-Examination WALTHAM, Mass., Sept. 20, 2024 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc.
    Read more...
分享